Filana Therapeutics Inc.
Organization details
- Legal name
- Filana Therapeutics Inc.
- Former names
- Cassava Sciences Inc Pain Therapeutics Inc
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Austin
- Headquarters state / province
- Texas
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- FLNA
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001069530
- EIN
- 91-1911336
Board of directors
-
Claude Nicaise · DirectorSince 2023
-
Dawn Carter Bir · DirectorSince 2025
-
Donnell Michael J. O. · DirectorSince 2023
-
Jill M. Quigley · DirectorSince 2026
-
Nadav Friedmann · Director · Chief Medical OfficerSince 2023
-
Patrick J. Md Scannon Ph.D. · DirectorSince 2023
-
Pierre Gravier · DirectorSince 2023
-
Remi Barbier · Director · President & CEOSince 2023
-
Richard Barry · Director · President & CEOSince 2023
-
Robert Eugene Anderson Jr. · DirectorSince 2023
-
Robert Z. Gussin · DirectorSince 2023
-
Sanford Robertson · DirectorSince 2023
Chief executives
Director election results
Annual meeting of June 11, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
85.0%
-
85.7%
-
87.1%
Board connections
5 of this board's directors also sit on 5 other boards. 4 are in the same sector.
- via Claude Nicaise and Jill M. Quigley
-
Sarepta Therapeutics Inc. Same sectorvia Claude Nicaise and Richard Barry
-
Gain Therapeutics Inc. Same sectorvia Claude Nicaise
-
Geron Corporation Same sectorvia Dawn Carter Bir
- via Sanford Robertson
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $997,077
- 6 purchases by 2 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 30, 2026 | Richard Barry Director, Officer (President & CEO) | Open-market purchase | +100,000 | $0.92 | $92,000 |
| Sep 29, 2026 | Richard Barry Director, Officer (President & CEO) | Open-market purchase | +206,813 | $0.90 | $186,132 |
| Sep 28, 2026 | Richard Barry Director, Officer (President & CEO) | Open-market purchase | +93,091 | $0.84 | $78,196 |
| Nov 24, 2025 | Robert Eugene Anderson Jr. Director | Open-market purchase | +8,600 | $2.90 | $24,940 |
| Nov 20, 2025 | Richard Barry Director, Officer (President & CEO) | Open-market purchase | +150,000 | $2.76 | $414,000 |
| Nov 19, 2025 | Richard Barry Director, Officer (President & CEO) | Open-market purchase | +73,385 | $2.75 | $201,809 |
| Sep 30, 2025 | Cook Robert Christopher Officer (Chief Operating & Legal Office) | Open-market purchase | +13,725 | $2.91 | $39,940 |
| Sep 22, 2025 | Richard Barry Director, Officer (President & CEO) | Open-market purchase | +7,172 | $2.28 | $16,352 |
| Sep 19, 2025 | Richard Barry Director, Officer (President & CEO) | Open-market purchase | +400 | $2.25 | $900 |
| Sep 19, 2025 | Richard Barry Director, Officer (President & CEO) | Open-market purchase | +46,908 | $2.29 | $107,419 |
| Sep 18, 2025 | Richard Barry Director, Officer (President & CEO) | Open-market purchase | +5,400 | $2.13 | $11,502 |
| Sep 18, 2025 | Richard Barry Director, Officer (President & CEO) | Open-market purchase | +185,233 | $2.24 | $414,922 |
| Nov 29, 2024 | Kupiec James William Officer (Chief Medical Officer) | Open-market sale | −4,000 | $3.87 | $15,480 |
| Nov 29, 2024 | Schoen Eric Officer (Chief Financial Officer) | Option exercise | +50,000 | $1.18 | $59,000 |
| Nov 29, 2024 | Schoen Eric Officer (Chief Financial Officer) | Open-market sale | −2,000 | $3.82 | $7,640 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Filana Therapeutics Inc.
Who is the CEO of Filana Therapeutics Inc.?
Remi Barbier is Filana Therapeutics Inc.'s President and CEO.
How many directors are on Filana Therapeutics Inc.'s board?
Filana Therapeutics Inc.'s board has 12 directors: Claude Nicaise, Dawn Carter Bir, Donnell Michael J. O., Jill M. Quigley, Nadav Friedmann, Patrick J. Md Scannon Ph.D., Pierre Gravier, Remi Barbier, Richard Barry, Robert Eugene Anderson Jr. and 2 others.
Are Filana Therapeutics Inc. insiders buying or selling shares?
Over the last 12 months, Filana Therapeutics Inc. insiders bought $997,077 of shares in 6 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="filana-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.